NFKB1 and neoplasm: Moreover, studies have found that anti-tumor cytotoxicity of T lymphocytes could be promoted in cancer patients through activation of TLR-mediated MAPK and NFKB signaling pathways (Chen Y. et al., 2017), suggesting whether TLR pathway regulates functions of TILs via MAP3K8 cascades need to be further studied.